
Exagen XGN
€ 2.96
-2.82%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Land |
|
IPO-Jahr |
2019 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
17.7 M |
Marktkapitalisierung |
$ 61 M |
EBITDA (LTM) |
$ -11.9 M |
P/E (LTM) |
-3.62 |
P/S (LTM) |
1.02 |
EPS (LTM) |
-1.0 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
$ 2.89 | -2.36 % | $ 93.8 K | Nasdaq Capital Market | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 118.02 | -0.13 % | $ 35.9 B | NYSE,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 14.12 | -0.56 % | $ 427 M | Nasdaq Global Market | ||
|
Celcuity
CELC
|
$ 107.49 | -0.75 % | $ 4.24 B | Nasdaq Global Select Market | ||
|
ICON Public Limited Company
ICLR
|
$ 108.18 | -0.08 % | $ 8.92 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 634.16 | -0.4 % | $ 51 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 130.4 | -1.88 % | $ 20.7 B | Nasdaq Global Select Market,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 27.85 | -0.52 % | $ 774 M | Nasdaq Global Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 282.57 | -1.29 % | $ 23.5 B | NYSE,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 77.51 | 1.58 % | $ 5.23 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 176.82 | -1.0 % | $ 8.76 B | NYSE,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 312.12 | -0.98 % | $ 27 B | NYSE,SPB | ||
|
Myriad Genetics
MYGN
|
$ 5.2 | 3.73 % | $ 482 M | Nasdaq Global Select Market,SPB | ||
|
NeoGenomics
NEO
|
$ 9.41 | -0.95 % | $ 1.21 B | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Natera
NTRA
|
$ 208.19 | 4.01 % | $ 20.5 B | Nasdaq Global Select Market,SPB | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Pacific Biosciences of California
PACB
|
$ 1.54 | -5.25 % | $ 462 M | Nasdaq Global Select Market,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Precipio
PRPO
|
$ 24.44 | -0.99 % | $ 31.7 M | Nasdaq Global Select Market | ||
|
Biodesix
BDSX
|
$ 16.16 | 2.6 % | $ 2.1 B | Nasdaq Global Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Senseonics Holdings
SENS
|
$ 7.31 | -11.75 % | $ 305 M | NYSE American | ||
|
Sotera Health Company
SHC
|
$ 15.78 | -0.77 % | $ 4.48 B | Nasdaq Global Select Market | ||
|
BioNano Genomics
BNGO
|
$ 1.11 | -2.96 % | $ 1.41 M | Nasdaq Capital Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 207.65 | -1.24 % | $ 23 B | NYSE,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 38.24 | -2.1 % | $ 1.94 B | Nasdaq Capital Market | ||
|
Danaher Corporation
DHR
|
$ 202.6 | -1.6 % | $ 144 B | NYSE,SPB | ||
|
Exact Sciences Corporation
EXAS
|
$ 103.35 | - | $ 19.5 B | Nasdaq Capital Market,SPB | ||
|
Bioventus
BVS
|
$ 8.8 | 0.34 % | $ 551 M | Nasdaq Global Select Market | ||
|
DarioHealth Corp.
DRIO
|
$ 10.5 | -2.33 % | $ 298 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 73.0 | -1.06 % | $ 28.5 B | Nasdaq Global Select Market,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 507.8 | -0.13 % | $ 191 B | NYSE,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Twist Bioscience Corporation
TWST
|
$ 46.79 | 1.95 % | $ 2.8 B | Nasdaq Global Select Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 24.2 | -3.82 % | $ 254 M | Nasdaq Global Market | ||
|
CareDx, Inc
CDNA
|
$ 18.64 | -0.56 % | $ 993 M | Nasdaq Global Market,SPB | ||
|
VolitionRx Limited
VNRX
|
$ 0.2 | -2.51 % | $ 19.2 M | NYSE American | ||
|
Waters Corporation
WAT
|
$ 309.78 | 0.86 % | $ 18.4 B | NYSE,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Guardant Health
GH
|
$ 93.28 | 1.14 % | $ 11.7 B | Nasdaq Global Select Market,SPB | ||
|
IQVIA Holdings
IQV
|
$ 173.24 | -0.6 % | $ 29.8 B | NYSE,SPB |